文献速递针灸推拿中医内科

针刺治疗癌症相关失眠的系统评价与荟萃分析

Acupuncture for cancer-related insomnia: A systematic review and meta-analysis.
PubMed 文献 · Phytomedicine · 2022-05-14

该系统评价与荟萃分析纳入22项随机对照试验,其中6项进行定量合成,探讨针刺对癌症相关失眠的疗效与安全性。荟萃分析显示,在正在接受抗肿瘤治疗的乳腺癌患者中,针刺较等待名单对照组显著改善匹兹堡睡眠质量指数(PSQI)总分(MD -1.92,95% CI -3.25至-0.59,p=0.005);手工针刺与艾司唑仑即刻有效率相似,但随访1周时有效率显著优于艾司唑仑。所有报告的针刺相关不良事件均为轻至中度。

要点

  • 针刺可改善正在接受抗肿瘤治疗的乳腺癌患者PSQI总分。
  • 手工针刺随访1周有效率优于艾司唑仑,即刻有效率与艾司唑仑相似。
  • 针刺相关不良事件均为轻至中度,无严重不良事件报告。

核心结论

  • 针刺在管理癌症相关失眠方面具有较大潜力,但需更多严谨设计和大样本研究验证。

研究设计与样本

  • 采用Jadad评分和RoB 2.0评估质量,异质性高时采用随机效应模型进行荟萃分析。

主要发现

  • 定性综述中55%的研究提示针刺对睡眠有益且无严重不良事件。
  • 荟萃分析显示,在正在接受抗肿瘤治疗的乳腺癌患者中,针刺较等待名单对照组显著改善PSQI总分(MD -1.92,95% CI -3.25至-0.59,p=0.005)。
  • 真针刺与假针刺在干预后PSQI评分变化上相似(MD -0.68,95% CI -2.44至1.07,p=0.44)。
  • 手工针刺与艾司唑仑即刻有效率相似(RR 0.94,95% CI 0.87至1.01,p=0.09),但随访1周时手工针刺有效率显著优于艾司唑仑(RR 1.25,95% CI 1.10至1.43,p=0.0009)。
  • 所有报告的针刺相关不良事件均为轻至中度。

关键数值与推荐

  • 针刺 vs 等待名单对照改善PSQI总分:MD -1.92(95% CI -3.25至-0.59,p=0.005),对象为正在接受抗肿瘤治疗的乳腺癌患者。
  • 真针刺 vs 假针刺PSQI评分变化:MD -0.68(95% CI -2.44至1.07,p=0.44)。
  • 手工针刺 vs 艾司唑仑即刻有效率:RR 0.94(95% CI 0.87至1.01,p=0.09)。
  • 手工针刺 vs 艾司唑仑随访1周有效率:RR 1.25(95% CI 1.10至1.43,p=0.0009)。

临床怎么用

  • 对于正在接受抗肿瘤治疗的乳腺癌患者合并失眠,可考虑针刺作为改善睡眠质量的辅助治疗。
  • 针刺相关不良事件多为轻至中度,安全性较好,但需注意研究间异质性高。
  • 手工针刺在随访1周时有效率优于艾司唑仑,可作为不耐受或不愿使用苯二氮䓬类药物的患者的替代选择。

局限性

  • 纳入研究在参与者特征和研究方法学上高度异质性。
  • 仅6项研究进入定量合成,样本量有限。
  • 多数研究招募特定癌症类型患者,乳腺癌亚组代表性最强,结果外推需谨慎。
  • 需更多严谨设计和大样本研究验证,尤其针对临床显著失眠患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cancer-related insomnia is a highly prevalent complaint in cancer patients. However, there is no meta-analytic synthesis explored the efficacy of acupuncture for cancer-related insomnia among cancer patients undergoing active cancer treatments. OBJECTIVE: This systematic review and meta-analysis were performed to explore the efficacy and safety of acupuncture for insomnia in people diagnosed with cancer. STUDY DESIGN: Systematic review and meta-analysis of existing randomized controlled trials on acupuncture in the treatment of cancer-related insomnia. METHODS: According to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) Statement, we identified and extracted the trials through November 2021 from ten databases and two trials record platforms (Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE, PUBMED, Web of Science, PsycINFO, Allied and Complementary Medicine, Cumulative Index to Nursing and Allied Health Literature, China National Knowledge Infrastructure, Wanfang Digital Journals, ClinicalTrials, World Health Organization International Clinical Trials Registry Platform). The quality of the trials was assessed using Jadad score and Risk of Bias (2.0). A meta-analysis was synthesized using the random-effects model if the included studies were in high methodological quality. RESULTS: A total of 690 studies were identified, with 22 were included in the review, and 6 of them were included in the quantitative synthesis. Studies were highly heterogeneous in terms of participant characteristics and study methodologies. Most studies recruited patients diagnosed with a specific cancer type, and breast cancer patients were the subgroup most represented. The qualitative review of available evidence suggested a beneficial efficacy of acupuncture on sleep without serious adverse events in several studies (55%). The meta-analysis revealed that acupuncture produced a significant improvement in the total Pittsburgh Sleep Quality Index (PSQI) score relative to the wait-list control among breast cancer patients undergoing active cancer treatments (MD -1.92, 95% CI -3.25 to -0.59, p = 0.005). Similar improvement of real and sham acupuncture on PSQI score change post-intervention was found (MD: -0.68, 95% CI: -2.44 to 1.07, p = 0.44). Manual acupuncture had similar effective rate as compared to estazolam immediately post-intervention (RR: 0.94, 95% CI: 0.87 to 1.01, p = 0.09), and had significantly better effective rate than estazolam at 1-week post-intervention follow-up (RR: 1.25, 95% CI: 1.10 to 1.43, p = 0.0009). All reported acupuncture related adverse events were mild or moderate in severity. CONCLUSION: Acupuncture has great potential to be used to manage cancer-related insomnia for cancer patients or survivors. More studies with rigorous designs and larger sample size are warranted to verify the efficacy and safety of acupuncture for insomnia among people diagnosed with cancer, in particular among those with clinically significant insomnia. REGISTRATION: PROSPERO (ID: CRD42021285844).

来源:Phytomedicine,查看原文。版权归原作者所有。

引用

  1. Zhang J, Zhang Z, Huang S, et al. Acupuncture for cancer-related insomnia: A systematic review and meta-analysis. Phytomedicine. 2022. PMID: 35636168. doi:10.1016/j.phymed.2022.154160

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。